• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Cytosorbents Corporation (CTSO)

    -NasdaqCM
    11.48 Up 0.12(1.06%) Feb 27, 4:00PM EST
    Add to Portfolio
    Prev Close:11.36
    Open:11.40
    Bid:9.88 x 100
    Ask:11.98 x 3000
    1y Target Est:17.19
    Beta:-1.8
    Earnings Date:Mar 30 - Apr 3 (Est.)
    Day's Range:11.15 - 11.50
    52wk Range:4.40 - 12.87
    Volume:112,343
    Avg Vol (3m):151,428
    Market Cap:281.35M
    P/E (ttm):N/A
    EPS (ttm):-0.84
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CTSO

    Comparison

    Symbol% ChgMkt Cap
    CTSOUp 1.06%281.35M
    BAXUp 0.70%37.52B
    LLYUp 0.20%74.42B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):67.44
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.89
    Quarterly EPS Est (Dec-14) :-0.23
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytoSorbents Corporation, a development stage company, is engaged in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent polymer technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback